Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03167125 · ClinicalTrials.gov registry record · NA
Participatory Research to Advance Colon Cancer Prevention
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 27,580
- Enrollment target
NCT03167125 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 27,580 participants.
The verdict
NCT03167125, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 27,580 participants
- Enrollment target
Study Summary
The overall goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population in a federally qualified health center that operates multiple clinics. This intervention study will test automated and live prompts to a direct-mail fecal testing program in two phases. In Phase I (Years 01 - 02), the investigators will tailor and define intervention components using a community-based participatory research approach called boot camp translation (BCT). The ultimate design of the intervention will be defined by patient and provider feedback from BCT. The investigators will then conduct a three-arm patient-randomized comparative effectiveness trial in two pilot clinics to compare 1) automated prompts (i.e., automated phone calls, text messages) to alert and remind patients to complete screening, 2) live prompts (i.e., live phone calls), and 3) a combination approach of automated plus live prompts. In Phase II (Years 03 - 05), the investigators will spread and test the spread of the adapted intervention to additional clinics within the partnering health center using a two-arm main trial. Both phases will be guided by an advisory group of clinicians, researchers, policy makers, and patients.
Interventions
- OTHER Automated Prompts
- OTHER Automated Plus Live Prompts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,580 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03167125
The ClinicalTrials.gov registry entry for NCT03167125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27,580 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Automated Prompts is the first listed.
NCT03167125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03167125 about?
NCT03167125 is a clinical study titled "Participatory Research to Advance Colon Cancer Prevention". The overall goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population in a federally qualified health center that operates multiple clinics. This intervention study will test automated and live prompts to a direct-mail fecal testing program in...
What is the current status of trial NCT03167125?
This trial is currently completed. It is a NA study. The enrollment target is 27,580 participants. The study started on 2017-09-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03167125?
The interventions under investigation include: Automated Prompts (OTHER), Automated Plus Live Prompts (OTHER).
Who is sponsoring clinical trial NCT03167125?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.